HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system.

Abstract
A comparison was made between the efficacy of mel Cy (Cymelarsan) and melarsen oxide to cure central nervous system trypanosomiasis in a chronic Trypanosoma brucei mouse model. Combination treatment with difluoromethylornithine and arsenical was used and it was found that there was only a marginal advantage in using the water-soluble mel Cy in terms of the numbers of mice cured.
AuthorsF W Jennings
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) 1992 May-Jun Vol. 86 Issue 3 Pg. 257-8 ISSN: 0035-9203 [Print] England
PMID1412647 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Arsenicals
  • Trypanocidal Agents
  • melarsen
  • melaminylthioarsenate
  • Eflornithine
Topics
  • Animals
  • Arsenicals (therapeutic use)
  • Central Nervous System Diseases (drug therapy)
  • Drug Therapy, Combination
  • Eflornithine (therapeutic use)
  • Mice
  • Models, Biological
  • Trypanocidal Agents (therapeutic use)
  • Trypanosomiasis, African (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: